The index case
A 39-year-old Burmese NICU physician with a known positive tuberculin skin test emigrated to Canada on July 1, 1997. Chest radiography in July 1997, conducted as part of his pre-immigration screening, was reported to be normal. He had never received therapy for latent TB infection. He began work at the NICU on July 1, 1998 (Box 1).
On July 20, 1998, the physician reported a fever and a productive cough, for which he sought medical attention. He began taking broad spectrum antibiotics, but his condition did not improve, and he stopped working in the NICU on July 25. Chest radiography on July 27 showed right upper lung pneumonia, and sputum samples were taken on Aug. 1. A sputum smear was found to be positive for acid-fast bacilli the next day, and on Aug. 19 the diagnosis was confirmed when the sputum culture was positive for Mycobacterium tuberculosis.
To ensure that all possible contacts were included when determining the possible duration of exposure, and taking the physician's work schedule into account, we included the 11 days before the index case exhibited symptoms as well as the 5 days that he was ill but continued to work.
Epidemiologic investigations and public health actions
We categorized visitors and neonates who might have been exposed to the index case as being at high risk (exposed without respiratory precautions to the index case during the 5-day period when he was symptomatic) or at low risk (exposed during the 11-day period when he was asymptomatic) of infection. Infants were also considered to be at low risk if they were not directly exposed to the index case or if they were receiving mechanical ventilation throughout the 16-day exposure period. All of the health care workers were considered to be at high risk. We attempted to contact all of these people to advise them of the risk and to encourage them to undergo a tuberculin skin test. People with a previously positive tuberculin skin test result were excluded from further investigation. People with a newly positive skin test result were referred for further assessment, invited to have chest radiography and then assessed for or given therapy for latent TB infection. People whose skin test result was negative were asked to undergo a follow-up test in 3 months.
Neonatal

5
Health care workers
Of the 219 health care workers who were identified as having potential exposure to the index case over the entire 16-day exposure period, 15 had previously had a positive tuberculin skin test result and were referred to a respirologist for further assessment ( Table 1 ). All of the 15 had chest radiography, and none showed active disease. Because there was no documentation of the positive skin test result in the staff health records of 2 of the 15, they were assumed to be newly positive. Both began taking, as prophylaxis, isonicotinic acid hydrazide, commonly known as isoniazid. Only these 2 people were deemed to require isoniazid therapy immediately. At 3 months, 179 of the 204 people who had a known negative skin test result underwent testing. The remaining 25 refused the follow-up skin test, some because they were afraid of the potential adverse effects of isoniazid. All of the 25 were referred to a respirologist and received counselling about the risk of illness if they had been infected. Those who refused follow-up testing were not excluded from work.
Visitors to the NICU
Visitors who were considered to be at high risk of infection were more likely than visitors who were considered to be at low risk to accept tuberculin skin testing (111/133 [83.5%] v. 16/168 [9.5%] respectively).
Of the 133 high-risk visitors at baseline, 22 were not tested, either because they could not be traced or because they refused testing, 109 had a negative skin test result and 2 had a newly positive skin test result and normal chest radiography. One of the 2 with a positive skin test result, an immigrant from a country with a high incidence of TB, received isoniazid therapy, and the other refused therapy. At 3 months, 114 high-risk visitors had follow-up skin tests, none of which was positive. The status of the remaining 17 people remained unknown, either because they were lost to follow-up or because they refused testing.
Only 1 of the 16 low-risk visitors who underwent a tuberculin skin test at baseline had a positive test result; 152 low-risk visitors were not tested. This person had immigrated from an area in which TB is endemic and had visited that area within the past year. Because there was no evidence of active disease, the person received therapy for latent TB infection. At 3 months, however, all 152 of the remaining low-risk visitors were contacted and tested, and 4 had a positive test result. Of these, 3 received therapy for latent TB infection. Contraindications to isoniazid were present in the fourth person.
Of the 7 visitors, both high and low risk, whose skin test result was ultimately positive for infection, active pulmonary TB was ruled out in all cases. Five received therapy for latent TB infection, 1 refused therapy and 1 was unable to take isoniazid because of contraindications.
Neonatal patients
Of the 50 neonates in the NICU who were exposed to the index case during the 5 days that he exhibited symptoms, baseline skin tests were performed on only 3, the results of which were negative ( Table 1 ). The remaining 47 infants were either too young (less than 3 months old) to obtain an accurate result (n = 43) or were discharged from the NICU before TB was diagnosed in the index case (n = 4). A total of 45 high-risk infants were tested at 3 months of age, and all of them had negative results. Of the remaining 5 infants, 3 were lost to follow-up and 2 were followed clinically by their physicians for signs and symptoms of infection after their caregivers refused to allow testing.
Because all exposed neonates are considered to be at risk of acquiring active TB, we urged parents to accept prophylaxis at baseline, including the parents of the 3 neonates whose baseline skin test result was negative. The parents of 36 accepted, and the infants received therapy for latent TB infection (isoniazid [10 mg/kg per day] and vitamin B 6 supplements). 6, 7 Therapy was discontinued at 3 months of age because the repeat skin test results were negative in all cases. Although not specifically evaluated, no infant showed clinical evidence of hepatotoxicity. The remaining 14 neonates did not receive prophylaxis for various reasons, including mechanical ventilation during exposure (n = 3), refusal by parent or physician (n = 5), contraindications to isoniazid because of elevated liver enzyme levels (n = 2), minimal exposure due to specific circumstances (n = 2) and discharge from the NICU (n = 2) at the time of assessment.
Of the 74 low-risk neonates, all but 2 were tested and had negative results at baseline and at 3-month followup. The caregivers of the remaining 2 refused testing. No infant in the low-risk neonatal group was given isoniazid therapy.
Comments
Our investigation of 124 neonates, 301 visitors and 219 health care workers did not identify any newly positive skin test results caused by exposure to the index case. (The index case's spouse was also tested, with a positive result. Because no previous skin test result was known and chest radiography was normal, she was given isoniazid therapy.) Although there is a risk of hepatotoxicity when neonates are given isoniazid, the infants in our study, in accordance with those of earlier studies, did not show hepatotoxicity.
Light and associates reported the exposure of 437 neonates to a nurse's aide with active pulmonary TB. 8 As was seen in our study, none of the infants had a positive skin test result at 3-month follow-up, and isoniazid therapy was discontinued. Of the 130 health care workers in that study who were exposed to the index case and tested, 4 (3.1%) had an initial positive result, and none of the remaining 126 had a positive test result at 3 months. The transmission rate was similar to that of our study. However, in a study by Steiner and associates, 2 of 1668 neonates exposed to a case with active TB were infected. 9 The rationale for treating latent TB infection in all exposed neonates stems from their immature cellular and humoral immune systems until 6-8 weeks of age. 10, 11 The neonatal lung is either deficient in macrophages or has macrophages with impaired phagocytosis. 10, 11 Moreover, impaired cell-mediated immunity may produce falsenegative skin test results. 3 At our institution, hospital employees are tested annually for TB, especially if they work in high-risk areas such as intensive care units. Some people working in the NICU were not screened because they did not comply with the regulations or because they refused testing. Because the index case had a positive tuberculin skin test result, he was further screened with chest radiography, the findings of which were normal. In retrospect, he should have received therapy for latent TB infection when his first skin test result was positive, but this did not happen.
There are several limitations to our study. Several people were not tested for infection at baseline, and therefore their skin test status was not known. Moreover, there were delays in contacting and testing all of the exposed people since each had to be contacted individually and appointments made for testing. Contacting the visitors was challenging because of the various geographic locations they came from. Finally, 11 visitors and neonates were lost to follow-up.
Because the results of our study and of earlier studies suggest that few, if any, new infections arise after exposure to an index case of active TB in NICUs, recommendations for appropriate management of TB exposure in this setting may need to be revised. It is possible that in the modern NICU setting, with incubators, mechanical ventilators and aggressive precautions against exposure to airborne pathogens, neonates may have increased protection against infection. Future recommendations regarding isoniazid therapy in this setting will likely be dictated on the basis of the level of exposure and the severity of disease in the index case.
In summary, we did not document any transmission from the index case to exposed neonates, health care workers or visitors to the NICU. Infants who were at high risk of infection were given isoniazid therapy without adverse sequelae. Although there are published guidelines for TB exposure in pediatrics, there are currently no recommendations for the management of neonates exposed to an active case of TB. From our experience and the few reported cases in the literature, we suggest that neonates with significant exposure to an index case with a high likelihood of transmitting infection (i.e., cavitary TB) be given isoniazid therapy if there are no contraindications. In addition, surveillance for TB infection in specific health care environments should be implemented on a regular basis to prevent active disease. This article has been peer reviewed.
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